skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
DEC-205/NY-ESO-1 Fusion Protein CDX-1401 (Code C84859)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401

Definition: A fusion protein consisting of a fully human monoclonal antibody directed against the endocytic dendritic cell (DC) receptor, DEC-205, linked to the tumor-associated antigen (TAA) NY-ESO-1 with potential immunostimulating and antineoplastic activities. The monoclonal antibody moiety of DEC-205/NY-ESO-1 fusion protein CDX-1401 binds to the endocytic DC receptor, which may result in DC endocytic internalization of this agent, specifically delivering the NY-ESO-1 moiety. DC processing of NY-ESO-1 may boost the immune system to mount a cytotoxic T-lymphocyte response (CTL) against cancer cells expressing NY-ESO-1. NY-ESO-1, a cell surface protein expressed in normal fetal and adult testes, is upregulated in a variety of tumor cell types.

Display Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401

Label: DEC-205/NY-ESO-1 Fusion Protein CDX-1401

NCI Thesaurus Code: C84859 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL412417  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
DEC-205/NY-ESO-1 Fusion Protein CDX-1401

External Source Codes: 
PDQ Closed Trial Search ID 651880
PDQ Open Trial Search ID 651880 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C84859
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom